Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine

scientific article

Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID173727
P698PubMed publication ID8557374

P2093author name stringSamuel JE
Moon HW
Whipp SC
O'Brien AD
Gordon VM
Bosworth BT
P2860cites workPathologic changes in edema disease of swine.Q49028216
Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigsQ50210545
Inheritance of resistance to oedema disease in the pig: experiments with an Escherichia coli strain expressing fimbriae 107.Q54241304
Dysentery in calves caused by an atypical strain of Escherichia coli (S102-9).Q54775920
Shiga-like toxin production from Escherichia coli associated with calf diarrhoeaQ57563911
Adhesive fimbriae produced in vivo by Escherichia coli O139:K12(B):H1 associated with enterotoxaemia in pigsQ64450790
Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxinQ68081670
Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomesQ70230160
New biological effect of edema disease principle (Escherichia coli-neurotoxin) and its use as an in vitro for this toxinQ70240179
Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in CanadaQ72542036
Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxinQ72548803
Oedema disease of swineQ75567527
Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin IQ24651553
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probesQ33449435
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coliQ33457864
Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stoolsQ33475757
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.Q34049372
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type IIQ35109009
An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swineQ36957798
Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variantsQ36977977
Shiga and Shiga-like toxinsQ37063416
An experimental model for subclinical edema disease (Escherichia coli enterotoxemia) manifest as vascular necrosis in pigsQ38533572
Shiga-like toxin production and attaching effacing activity of Escherichia coli associated with calf diarrheaQ38535544
Observations on the intoxication produced in mice and rabbits by the neurotoxin of Shigella shigae.Q40288665
The role of adhesive F107 fimbriae and of SLT-IIv toxin in the pathogenesis of edema disease in pigs.Q40711686
Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigsQ41295987
Immunization of pigs with a purified Shiga-like toxin II variant toxoidQ43813100
The production of oedema disease and diarrhoea in weaned pigs by the oral administration of Escherichia coli: factors that influence the course of the experimental diseaseQ45117854
Verification of the protective effect of a toxoid vaccine against edema disease of weaned piglets in an infection modelQ46133113
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)55-60
P577publication date1996-01-01
P1433published inInfection and ImmunityQ6029193
P1476titleVaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine
P478volume64

Reverse relations

cites work (P2860)
Q37190873A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model
Q38519709Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro
Q33348633Development of DNA vaccines against hemolytic-uremic syndrome in a murine model
Q24533466Diarrheagenic Escherichia coli
Q37427473Effectiveness of F18+ Fimbrial Antigens Released by a Novel Autolyzed Salmonella Expression System as a Vaccine Candidate against Lethal F18+ STEC Infection
Q35246991Enterohemorrhagic Escherichia coli senses low biotin status in the large intestine for colonization and infection
Q42956985Escherichia coli strains causing edema disease in northern Vietnam share an identical verotoxin 2e.
Q51061486Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study.
Q33965188Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.
Q24550740Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections
Q42940862Prevention of edema disease in pigs by passive immunization.
Q33923243Prevention of edema disease in pigs by vaccination with verotoxin 2e toxoid.
Q35012362Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.
Q30418998Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.
Q35665444Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid
Q33883465Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli
Q35068024Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group
Q36929589Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their dams
Q54281847Zinc oxide enriched peat influence Escherichia coli infection related diarrhea, growth rates, serum and tissue zinc levels in Norwegian piglets around weaning: five case herd trials.

Search more.